Literature DB >> 7913093

Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism.

M Cheron1, E Abachin, E Guerot, M el-Bez, M Simonet.   

Abstract

We demonstrate that DNA restriction fragment length polymorphism determined by pulsed-field gel electrophoresis is very useful in the investigation of the epidemiology of hospital-acquired infections caused by Alcaligenes denitrificans subsp. xylosoxydans. This approach showed that hospital-acquired infections caused by this opportunistic pathogen over a 6-month period in 10 patients hospitalized in an intensive care unit and a surgical unit were not a true outbreak. In addition, this molecular typing method established that the respiratory therapy equipment was the source of the contamination of two patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913093      PMCID: PMC267173          DOI: 10.1128/jcm.32.4.1023-1026.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers.

Authors:  B Gahrn-Hansen; P Alstrup; R Dessau; K Fuursted; A Knudsen; H Olsen; H Oxhøj; A R Petersen; A Siboni; K Siboni
Journal:  J Hosp Infect       Date:  1988-07       Impact factor: 3.926

2.  Two resistance phenotypes to beta-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to beta-lactamase types.

Authors:  A Philippon; K Mensah; G Fournier; J Freney
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

3.  Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution.

Authors:  J Reina; M Antich; B Siquier; P Alomar
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

4.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  Separation of large DNA molecules by contour-clamped homogeneous electric fields.

Authors:  G Chu; D Vollrath; R W Davis
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

6.  Achromobacter xylosoxidans osteomyelitis.

Authors:  R D Walsh; N C Klein; B A Cunha
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

7.  Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush.

Authors:  L H Pham; C Brun-Buisson; P Legrand; A Rauss; F Verra; L Brochard; F Lemaire
Journal:  Am Rev Respir Dis       Date:  1991-05

8.  Nosocomial colonization and infection by Achromobacter xylosoxidans.

Authors:  M E Reverdy; J Freney; J Fleurette; M Coulet; M Surgot; D Marmet; C Ploton
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

Review 9.  Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature.

Authors:  J B Spear; J Fuhrer; B D Kirby
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Cerebral ventriculitis associated with Achromobacter xylosoxidans.

Authors:  S Shigeta; Y Yasunaga; K Honzumi; H Okamura; R Kumata; S Endo
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

View more
  14 in total

1.  Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser.

Authors:  E Siebor; C Llanes; I Lafon; A Ogier-Desserrey; J M Duez; A Pechinot; D Caillot; M Grandjean; N Sixt; C Neuwirth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

2.  Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.

Authors:  H Peltroche-Llacshuanga; H Peltroche-Llacsahuanga; H Kentrup; G Haase
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

3.  Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.

Authors:  H Vu-Thien; D Moissenet; M Valcin; C Dulot; G Tournier; A Garbarg-Chenon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

4.  Fluorescent whole-cell hybridization with 16S rRNA-targeted oligonucleotide probes to identify Brucella spp. by flow cytometry.

Authors:  L Fernández-Lago; F J Vallejo; I Trujillano; N Vizcaíno
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans.

Authors:  D Decré; G Arlet; E Bergogne-Bérézin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

6.  Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxidans by DNA restriction fragment length polymorphism.

Authors:  W Frederiksen
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Proper combination for Alcaligenes xylosoxidans subsp. xylosoxidans.

Authors:  P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  Transmission of nonfermenting gram-negative bacilli by multiple-dose inhalers.

Authors:  K Mihalik; G Demko
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

9.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

10.  Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

Authors:  M Kaur; P Ray; M Bhatty; M Sharma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.